Skip to main content
Smart Investors Daily
Coloplast A/S logo

OTC · CLPBY

Coloplast A/S

Healthcare · Medical - Instruments & Supplies

$6.60

Up+$0.14 (+2.17%)

Updated Oct 11, 2026, 8:00 PM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
19.84B
P/E ratio
31.03
Dividend yield
5.36%
52-week range
— – —
Volume
11.71K
Avg. volume
405.67K

Price performance · CLPBY

CLPBY price history

1M range · 0 trading sessions · Daily adjusted prices

CLPBY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CLPBY news

The latest Smart Investors Daily articles mentioning CLPBY.

CLPBY research

Overview

Company profile and research snapshot.

Company profile

COLOPLAST AS SP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$14.45
Implied upside
—
Analysts
—
CLPBY recent ratings
DateFirmRatingTarget
Sep 23, 2026ROTHSCHILD & CO REDBURNNeutral—
Sep 23, 2026JEFFERIESBuy—
Sep 22, 2026JYSKE BANKBuy—
Sep 21, 2026BERENBERGHold—
Sep 10, 2026BAADER EUROPE / ALPHAVALUEBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

Coloplast A/S - Major shareholder announcement

Major shareholder announcement Reference is made to the press release issued by Coloplast A/S on 4 September 2026 regarding the expected implementation of the generational change in the ultimate ownership of Coloplast A/S. Coloplast A/S hereby announces that on 1 October 2026, Coloplast A/S has received the following major shareholder notification: NPLH Holding ApS, a company 100% owned and controlled by Niels Peter Louis-Hansen, has transferred, by way of a gift, all its shares in Coloplast Hol

Yahoo · Sep 24, 2026

Coloplast A/S - Financial Calendar 2026/27

Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards,Investor RelationsColoplast A/STel. +45 4911 1800 For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. +45 4911 1111 Kristine Husted MunkSenior Director, Investor RelationsTel. +45 4911 1800 / +45 4911 3266Email: [email protected]

Yahoo · Sep 4, 2026

Supporting the continued long-term and stable ownership of Coloplast

Coloplast has been informed that the Danish Financial Supervisory Authority (FSA) has today announced that it has notified Niels Peter Louis-Hansen that it has granted an exemption from the obligation to make a mandatory takeover offer to the shareholders of Coloplast A/S in connection with the contemplated transfer of a controlling indirect ownership interest in Coloplast A/S from NPLH Holding ApS to a non-profit foundation. Reference is made to the Danish Financial Supervisory Authority’s prio

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.